Peak6 Investments LLC Alkermes Plc. Transaction History

Peak6 Investments LLC

  • $43.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 08, 2019
SELL
$19.51 - $24.28 $1.63 Million - $2.03 Million
-83,612 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$21.47 - $37.33 $1.4 Million - $2.43 Million
65,103 Added 351.74%
83,612 $1.89 Million
Q1 2019

May 15, 2019
BUY
$28.4 - $36.49 $525,655 - $675,393
18,509 New
18,509 $675,000

Others Institutions Holding ALKS

# of Institutions
363
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.67B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email